Important Notice: All grants and sponsorships must be submitted in NGCS by October 1, 2026. Submissions received by this date will receive a full review in NGCS. The new platform is scheduled to launch on November 16, 2026. Any submissions planned after October 1st, should be held until the new system is launched.

Novartis is committed to meeting the needs of patients by supporting non-profit patient advocacy organizations in educating and helping patients, caregivers, and the public in therapeutic areas where our company has an interest.

We will evaluate patient education grant requests that are independent of commercial bias and are non-promotional in nature. Patient education grants can be requested to support a variety of different activities including disease awareness, live events, web-based education, print/media, newsletters, websites, seminars, etc. We will only accept grant requests for patient education programs from 501(c)3, 501(c)4, or 501(c)6 nonprofit organizations.

In order to be considered, a complete grant application package must be submitted via the online portal at least 60 calendar days prior to the event date. If the completed grant application package is not received at least 60 days prior to the event date, the grant request may be denied.

Required documents for submitting a Patient Education Grant request

  • Letter of request
  • Proposed topics/outline/agenda
  • Detailed needs assessment
  • Detailed budget
  • Outcomes measurement plan
  • Current W9 (signed and dated)

Following are examples of submissions that will not be accepted for a Patient Education Grant request

  • Grants or payments to entities that are not 501(c)3, 501(c)4, or 501(c)6 non-profit organizations 
  • Promotional exhibit or display space (please contact your local Novartis Sales or Marketing Representative regarding requests for exhibit fees)
  • Funding to individuals
  • Capital campaigns, building funds, or operating expenses (e.g., salaries, benefits)
  • Personal travel
  • Requests that include activities such as smoking and/or gambling
  • Requests that include spa or resort activities
  • Textbooks, medical device- or equipment-related requests
  • Requests for programs that are already in progress
  • Treatment specific education
  • Housing or travel for event/program attendees
  • Activities held in lavish venues/resort locations
  • Grants not within the therapeutic areas of interest to Patient Advocacy
  • Activities involving and or geared predominantly toward HCPs

Novartis will receive and review patient education grant requests in the following areas. Please note that these areas are subject to change and the funding availability may vary. (Note: These are also the same areas for Patient Advocacy Sponsorships and Memberships.)

Non-Oncology

  • Arthritis
  • Asthma/Allergy
  • Cardiovascular/Heart Failure
  • Dermatology
  • Multiple Sclerosis
  • Non-Therapeutic Area Specific* (Excludes Philanthropic requests)
  • Neuroscience
  • Ophthalmology
  • Transplant

Oncology

  • Breast Cancer
  • Cell and Gene Therapies
  • Gastrointestinal Stromal Tumors (GIST)
  • General Education for Patients with Cancer
  • Immune Thrombocytopenia (ITP)
  • Iron Overload
    • Thalassemia
    • Myelodysplastic Syndromes
  • Leukemia/Lymphoma
  • Lung Cancer
  • Melanoma
  • Multiple Myeloma
  • Neuroendocrine Tumors
  • Rare Diseases 
    • Acromegaly
    • Tuberous Sclerosis Complex
    • General Education for Patients with Rare Diseases
  • Renal Cell Cancer
  • Sickle Cell Disease
  • Soft Tissue Sarcoma

Important Notice: All grants and sponsorships must be submitted in NGCS by October 1, 2026. Submissions received by this date will receive a full review in NGCS. The new platform is scheduled to launch on November 16, 2026. Any submissions planned after October 1st, should be held until the new system is launched.

Submit your education grant request